Vesalius Longevity Labs (SPV) Inc. research brief

CIK 2056924 Copy CIK

Generated Nov. 8, 2026, 6:44 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: VANCOUVER A1. Reported legal jurisdiction: BRITISH COLUMBIA, CANADA. These do not establish investor residence or where funds were deployed.

• March 19, 2026 · D · 0002060755-26-000018 · Source evidence

  Reported offering amount: 6712500 USD. Reported amount sold: 6712500 USD.

• May 13, 2025 · D · 0002060755-25-000010 · Source evidence

  Reported offering amount: 250000 USD. Reported amount sold: 250000 USD.

• March 27, 2025 · D · 0002060755-25-000003 · Source evidence

  Reported offering amount: 895000 USD. Reported amount sold: 895000 USD.

• Feb. 19, 2025 · D · 0001183740-25-000024 · Source evidence

  Reported offering amount: 1700000 USD. Reported amount sold: 1700000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Vesalius Longevity Labs (SPV) Inc. research brief,” CIK 2056924, retrieved Nov. 8, 2026, 6:44 a.m.. Cite the specific accessions used. No amounts have been summed.